Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Co-Chief Executive Officer

Chief Medical Officer

Chief Financial Officer

Chief Legal Officer

Chief Commercial Officer

Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrop...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-16	Premium	acquired	Premium	Premium	Premium	Co-Chief Executive Officer
2024-04-16	Premium	acquired	Premium	Premium	Premium	Co-Chief Executive Officer
2024-04-16	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-04-16	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-04-16	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-03-05	Premium	sold	Premium	Premium	Premium	Co-Chief Executive Officer
2024-03-05	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2024-03-05	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-03-05	Premium	sold	Premium	Premium	Premium	Co-Chief Executive Officer
2024-02-26	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-02-26	Premium	acquired	Premium	Premium	Premium	Co-Chief Executive Officer
2024-02-26	Premium	acquired	Premium	Premium	Premium	Co-Chief Executive Officer
2024-02-26	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-23	Premium	sold	Premium	Premium	Premium	Chief Legal Officer
2024-01-25	Premium	gifted	Premium	Premium	Premium	-
2024-01-16	Premium	gifted	Premium	Premium	Premium	-
2024-01-09	Premium	sold	Premium	Premium	Premium	Co-Chief Executive Officer
2024-01-09	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2024-01-09	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2024-01-09	Premium	sold	Premium	Premium	Premium	Co-Chief Executive Officer
2023-12-27	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2023-12-15	Premium	bought	Premium	Premium	Premium	-
2023-11-27	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-11-16	Premium	acquired	Premium	Premium	Premium	Co-Chief Executive Officer
2023-10-31	Premium	gifted	Premium	Premium	Premium	Chief Financial Officer

AMLX - Amylyx Pharmaceuticals, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for AMLX